Investing

Puma Biotechnology : PBYI

PBYI

Stock Data

$6.42

$0.44 (6.41%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Puma Biotechnology Inc is a Los Angeles-based biopharmaceutical firm dedicated to advancing cancer care globally. It specializes in developing innovative treatments, with a keen focus on breast cancer and HER2 mutation-positive solid tumors. Its flagship product, neratinib, is available in both oral and intravenous forms, targeting early stage to advanced HER2-positive breast cancer. Founded in 2010, Puma Biotechnology has formed strategic partnerships with several international companies, including Pfizer, to expand its reach and impact in the fight against cancer.

All Puma Biotechnology Articles

49 Articles

Chris MacDonald | Oct 7, 2025 at 10:46 AM EDT

3 High-Flying Stocks Under $10 to Buy Hand Over Fist Right Now

There’s a small portion of my portfolio I allocate toward companies I’d put in the “higher risk” bucket. For me,…

Lee Jackson | Oct 16, 2021 at 6:05 AM EDT

Sizzling Buy-Rated Biotechs Highlight 5 Top Stocks Under $10

These are five stocks for aggressive investors looking to get share count leverage on companies that have sizable upside potential.…

Lee Jackson | Sep 28, 2021 at 8:42 AM EDT

Tuesday’s Top Analyst Upgrades and Downgrades: Applied Materials, Aurora Cannabis, Chewy, Coinbase, Kinder Morgan, Macy’s, Qualcomm, Wells Fargo and More

Tuesday's top analyst upgrades and downgrades included Applied Materials, Aurora Cannabis, Chewy, Coinbase Global, Kinder Morgan, Macy's, Qualcomm and Wells…

Chris Lange | Dec 12, 2019 at 9:15 AM EST

Why These Breast Cancer Study Results Look So Promising

Puma Biotechnology shares made a handy gain early on Thursday after the company presented updated results from its Phase 2…

Jon C. Ogg | Dec 6, 2019 at 9:00 AM EST

Top Analyst Upgrades and Downgrades: Anthem, Ciena, Dollar General, Encana, Lennar, Lululemon, Sage Therapeutics, Target, Tesla, Trade Desk, Yext and More

Friday's top analyst upgrades and downgrades included Anthem, Ciena, Dollar General, Encana, Lennar, Lululemon Athletica, Sage Therapeutics, Target, Tesla, Trade…

Jon C. Ogg | Oct 8, 2019 at 8:50 AM EDT

Top Analyst Upgrades and Downgrades: Apollo, BlackRock, Cloudflare, Green Plains, Microsoft, Oracle, Target, TJX and More

Tuesday's top analyst upgrades, downgrades and initiations included Apollo Global Management, BlackRock, Cloudflare, Green Plains, Microsoft, Oracle, Target and TJX…

Chris Lange | Sep 4, 2019 at 10:35 AM EDT

What This Recent FDA Move Could Mean for Breast Cancer Patients With Brain Metastases

Puma Biotechnology shares jumped early Wednesday after FDA news about Puma’s breast cancer treatment. However, Puma shares quickly fell off…

Jon C. Ogg | Nov 19, 2018 at 9:00 AM EST

Top Analyst Upgrades and Downgrades: American Air, BlackBerry, Mallinkrodt, PG&E, RingCentral, Southwest Airlines, Yeti and More

  Stocks were indicated to open lower on Monday after weekend news that sounds like a China trade deal is…

Paul Ausick | Nov 2, 2018 at 4:04 PM EDT

Puma Biotech, General Electric Plummet into Friday’s 52-Week Low Club

General Electric, Encana Energy, Puma Biotechnology, and Kraft Heinz all posted new 52-week lows Friday.

Jon C. Ogg | Nov 2, 2018 at 8:55 AM EDT

Top Analyst Upgrades and Downgrades: Abiomed, Allscripts, Apple, Carbonite, Kraft Heinz, L3, Southern Copper, Starbucks, VeriSign, XPO and More

  Stocks were indicated to open higher on China trade deal hopes and after a stronger nonfarm payrolls report. While…

Chris Lange | Jun 26, 2018 at 11:35 AM EDT

Can Puma Biotechnology Break In to Europe?

Puma Biotechnology shares were climbing on Tuesday after the company announced that it expects a positive outcome in Europe.

Lee Jackson | May 11, 2018 at 9:00 AM EDT

Top Analyst Upgrades and Downgrades: AMC, Alkermes, Echostar, Kohls, L Brands, US Bancorp, Sarepta Therapeutics and More

The top analyst upgrades, downgrades and other research calls from Friday included AMC, Alkermes, Echostar, Kohls, L Brands, US Bancorp…

Jon C. Ogg | Apr 17, 2018 at 10:00 AM EDT

Breast Cancer Drug Can Bring Exponential Sales Growth for Puma Biotechnology

The world of biotech can be a rags-to-riches story for companies that build up a drug candidate and secure FDA…

Jon C. Ogg | Apr 12, 2018 at 9:00 AM EDT

Top Analyst Upgrades and Downgrades: Albermarle, American Airlines, Ellie Mae, Johnson & Johnson, Mallinckrodt, Mylan, NetApp, Southwest Air and More

The top analyst upgrades, downgrades and other research calls from Thursday include Albermarle, American Airlines, Ellie Mae, Johnson & Johnson,…

Chris Lange | Jan 24, 2018 at 10:50 AM EST

Why Analysts Are Slashing Their Targets for Puma Biotechnology

Puma Biotechnology saw its shares take a dive on Wednesday following regulatory events in Europe for its breast cancer treatment.